3649 results for «464»
3649 results
Leading innovation for patients with valvular heart disease
24 Nov 2024 – From PCR London Valves 2024
Discover the newest advancements in transcatheter heart valves and their role in modern lifetime management of valvular heart disease. Review the latest clinical outcomes demonstrating improved patient care and explore how a diverse device portfolio addresses a wide range of valve anatomies.
Rendez-vous with Myval THV series and Landmark RCT subset analysis
24 Nov 2024 – From PCR London Valves 2024
Discover this interactive session during which the audience learns about and discusses the novel Myval THV Series, a series of valves featuring intermediate and XL sizes. They also discuss the results of the pivotal LANDMARK randomized controlled trial and its relevance in clinical practice.
Optimisation of your valve implantation to ensure lifelong outcomes using a novel self-expanding valve
24 Nov 2024 – From PCR London Valves 2024
Gain insights into the importance of valve optimization post-implantation to secure acute and long-term outcomes. In this session, you will discover the new features and benefits of the ACURATE Prime platform illustrated by a recorded case, and compare how different TAVI platforms perform when treating larger...
Innovation never stops: Cardiovalve in action!
24 Nov 2024 – From PCR London Valves 2024
Join us as we explore the latest advancements in transcatheter tricuspid valve replacement technologies. This session develops the anatomical and imaging challenges associated with this rapidly developing clinical field and provides an update on the Cardiovalve tricuspid clinical program, illustrated by a recorded case.
RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation
25 Nov 2024 – From PCR London Valves 2024
Join this compelling session focused on the transcatheter treatment of mitral and tricuspid regurgitation. Explore detailed case discussions, including a mitral regurgitation case, a challenging MitraClip procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how...
A window into the future - Expanding horizons for patients with long life expectancy with the Evolut FX + TAVI system
25 Nov 2024 – From PCR London Valves 2024
Gain insights into the key considerations when performing TAVI in patients with long life expectancy, including long-term outcomes, valve durability, and the feasibility of future redo-TAVI. Discover the latest data on TAVI in women and patients with small annulus anatomy, as well as a live case...
Tailoring tricuspid interventions with the EVOQUE and PASCAL Precision systems
25 Nov 2024 – From PCR London Valves 2024
Catch up on this engaging session, featuring a parallel case study of two high-risk patients with severe tricuspid regurgitation. Discover how the PASCAL system is used to treat diverse TR anatomies and explore patient selection and management strategies for the EVOQUE system. Watch a recorded case...
The many faces of complex TAVI
25 Nov 2024 – From PCR London Valves 2024
Learn how to navigate challenging cases illustrating the complexities of TAVI procedures and the importance of device selection and implantation technique. Discover strategies for tackling issues like bicuspid aortic stenosis, difficult access, and complex anatomies.
TAVR implantation techniques: are they the same for all self-expanding TAV platforms?
25 Nov 2024 – From PCR London Valves 2024
Explore the differences between currently available self-expanding TAVI platforms and how they influence device selection and procedural techniques. A panel of experts discuss the pros and cons of these platforms and valuable tips and tricks to tackle various anatomical challenges effectively.
Top Innovations
20 Nov 2023 – From PCR London Valves 2023
Discover the future of cardiac care with these 3 top innovations! ARTERY, revolutionizing structural heart treatment, Vesalius Transfemoral DMR Repair, combining chordal and annular support in one-transfemoral device, and Approxima, a right ventricular reshaping device, offering a fresh perspective on tricuspid regurgitation.
!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice
20 Nov 2023 – From PCR London Valves 2023
Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.
Relief for the unrelievable: the role of the Reducer for refractory angina
15 May 2024 – From EuroPCR 2024
Explore the incidence and impact of refractory angina, observe a real-life Reducer implantation procedure with step-by-step analysis and discussions, gain insight into the coronary sinus mechanism of action and implantation techniques, grasp the indications for the Reducer, and review available clinical data in this session.
Transformative imaging in the clinical pathway of transcatheter tricuspid valve interventions
16 May 2024 – From EuroPCR 2024
Explore this EuroPCR 2024 session for a comprehensive understanding of the imaging pathway in transcatheter tricuspid valve interventions, including diagnosis, therapy, and post-procedural follow-up, discover innovative, transformative imaging techniques such as 4D intracardiac echocardiography and dual-source photon-counting CT, and learn how these innovations can be applied in...
Left main and complex bifurcation stenting
14 May 2024 – From EuroPCR 2024
Watch this session focused on a patient with distal left main stenosis to understand that the stepwise provisional side branch (SB) stenting strategy is the standard approach for most left main trifurcation lesions. Discover the importance of optical frequency domain imaging for strategy determination and bifurcation...
Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options
15 May 2024 – From EuroPCR 2024
In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...
From innovation to reality: the impact of Cre8 EVO technology on complex PCI
15 May 2024 – From EuroPCR 2024
This session is a good opportunity to delve into the contemporary technical and clinical complexities surrounding complex PCIs in challenging patient cases. Explore the necessary tools and treatment strategies to enhance peri-procedural and long-term clinical outcomes, and follow discussions on the unique technologies of Cre8 EVO...
LANDMARK RCT - Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024 – From EuroPCR 2024
This session provides an overview of the early outcomes of the LANDMARK trial, a randomized non-inferiority trial comparing TAVI devices. It examines baseline characteristics, the significance of intermediate sizes according to MSCT recommendations, real-world representative cases from the LANDMARK RCT, insights from quantitative aortography and echocardiography...
The future of STEMI care: a new treatment for bridging the gap from diagnosis to treatment
14 May 2024 – From EuroPCR 2024
Watch this session to delve into the crucial role of pre-hospital STEMI diagnosis and treatment. Gain insights into the significance of early intervention and explore previous facilitated PCI trials in STEMI. Additionally, learn about a promising new agent for pre-hospital STEMI treatment, offering potential advancements in...
Crossing the finishing line - Latest best practices and technologies for large hole arterial and venous closure
14 May 2024 – From EuroPCR 2024
Tune in to this session for insights on optimizing vascular access and closure techniques. Explore steps like thorough CT analysis, ultrasound-guided puncture, and contingency plans for alternative access methods to minimize complications. Discover a novel patch-based closure approach offering immediate hemostasis and simplified usage, addressing issues...
Heterotopic tricuspid valves: to who, when and how?
15 May 2024 – From EuroPCR 2024
Watch this session to gain comprehensive insights into the use, safety, and efficacy of heterotopic tricuspid valves. Learn to identify ideal candidates with severe tricuspid regurgitation, understand key procedural factors for successful implantation, and receive tips on valve systems and anatomy. The session also includes...
